Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes

EMA Collaboration Task Force

EMA Collaboration Task Force


EMA Collaboration Task Force

Mission: Closely collaborate with the European Medicine Agency (EMA) to inform them about the progress of in silico methods and learn about EMA requirements to accept digital evidence

The European Medicines Agency (EMA) plays a crucial role in supporting innovation and advancing the development of medicines within the European Union (EU) and its involvement with
in silico technologies. This aligns perfectly with the Avicenna Alliance aims to ensure that in silico evidence becomes an integral part of regulatory practice, benefiting patients and fostering healthcare breakthroughs.

The Avicenna Alliance collaborates with the EMA, along with other stakeholders, to advance
in silico methods and together they engage with European authorities to promote the role of in silico techniques.

In summary, the EMA Task Force actively collaborates with stakeholders to advance innovative approaches, including
in silico technologies, to enhance the safety and efficacy of medicines in the EU.


  • Publish a white paper about the use of in silico methods to provide digital evidences for pharmaceutical applications.
  • Informal small-scale closed meetings every 2 months to have fast communication on most interesting topics to work on.
  • Public Triple Helix expertise exchange workshops between EMA, industry & academia: first edition on drug-device interaction in Q2, follow up in Q3.

Liesbet Geris

Liesbet Geris

Research & Technology Working Group Leader

Executive Director, VPH Institute

Martha De Cunha Maluf-Burgman

Martha De Cunha Maluf-Burgman

Policy Development Working Group Leader

Director Regulatory Affairs Digital Health, Edwards Lifesciences



News Get Ready for Avicenna Day (AAD) 2024!

Get Ready for Avicenna Day (AAD) 2024!

On September 3rd, 2024, Stuttgart (Germany) will host the Avicenna Day (AAD) 2024.

News Welcome ADSILICO to the Avicenna Alliance!

Welcome ADSILICO to the Avicenna Alliance!

We are delighted to announce that ADSILICO has officially joined the Avicenna Alliance! This partnership marks a significant milestone in our collective mission to advance in silico medicine and foster innovation in healthcare.

News Welcome Bioreme

Welcome Bioreme

We are thrilled to welcome BIOREME (Integrating data-driven BIOphysical models into REspiratory MEdicine), a pioneering collaborative network based in the UK, as Avicenna new Partner!

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry